Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

59889 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Caribou Biosciences : CB-012 AMpLify Study Trial Design ASCO 2024
PU
Travel group FTI files for insolvency - future trips canceled
DP
Wacker Chemie : Opens mRNA Competence Center in Halle an der Saale, Germany
PU
DD: SIMONA Aktiengesellschaft: Matthias Schoenberg, buy
EQ
Harpoon Therapeutics : June 3, 2024
PU
LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer
AQ
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
BU
Enlivex Receives Regulatory Authorization for the Initiation of a Placebo-Controlled Phase I/II Trial Evaluating Allocetra in Up To 46 Patients with Thumb Osteoarthritis
GL
Lundbeck presents innovative first in human trial design of Lu AG13909 for potential treatment of congenital adrenal hyperplasia
AQ
Enlivex Receives Regulatory Authorization for the Initiation of a Placebo-Controlled Phase I/II Trial Evaluating Allocetra in Up To 46 Patients with Thumb Osteoarthritis
AQ
Calamos Launches CPNJ, First ETF to Provide 100% Downside Protection to Nasdaq-100® with a 10.20% Upside Cap Over One Year
PR
Avolta : AGM 2024 Minutes
PU
Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024
BU
SAS : CELEBRATES PRIDE IN OSLO, STOCKHOLM, AND COPENHAGEN
PU
Factbox-Key facts about the European Parliament election
RE
Northern Data Group launches AI Accelerator to Power the World’s Most Innovative Ideas
EQ
Sirius Real Estate : Annual Report & Accounts 2024
PU
Deutsche Pfandbriefbank AG: pbb to offer partial repurchase of three benchmark bonds
EQ
Equinor : Accounts represented on the AGM
PU
Sirius Real Estate : Annual Report And Accounts 2024
PU
Explainer-European election: How the EU says Russia is spreading disinformation
RE
FTI Consulting Adds Senior Chemicals Industry Expert to Further Expand Business Transformation Practice in Europe
GL
Analysis: Wind and solar capacity in the EU increased by almost two thirds
DP
Transcript : Regal Partners Limited, Merricks Capital Pty Limited - M&A Call
DIARY-Top Economic Events to July 31
RE
Rescue worker dies in southern Germany floods
RE
Transcript : Autolus Therapeutics plc - Special Call
Sensei Biotherapeutics : Company Presentation June 2024
PU
ASCO 2024: Topline SNS-101 Dose Escalation Data
PU
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
BU
Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
BU
Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response
AQ
Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response
GL
Eli Lilly and Company Announces Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting
CI
DIARY-Top Economic Events to July 31
RE
PCM Fund : Third Quarter Report
PU
Centogene N : Minutes of the 2024 Annual General Meeting of Shareholders - Centogene N.V.
PU
Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024
GL
Transcript : Laurentian Bank of Canada - Analyst/Investor Day
AerCap N : Minutes AGM 2024
PU
France's Socialists snap at Macron's heels ahead of European election
RE
Transcript : Invesco Ltd. Presents at Bernstein?s 40th Annual Strategic Decisions Conference, May-31-2024 10:00 AM
Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression
BU
DD: SIMONA Aktiengesellschaft: Matthias Schoenberg, buy
EQ
Appendix 4: Non-Financial Report 2023
PU
Renewed record results in 2023
EQ
Valora is the first retailer to label its own-brand products with both Nutri-Score and Eco-Score
EQ
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GL
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
AQ
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation
GL
No results for this search
  1. Stock Market
  2. Advanced search
  3. crossen an der oder - altes schloss
  4. News